Korea United Pharm Inc. (KRX:033270)
19,080
-50 (-0.26%)
Jan 30, 2026, 3:30 PM KST
Korea United Pharm Market Cap
Korea United Pharm has a market cap or net worth of 280.72 billion as of January 30, 2026. Its market cap has increased by 2.70% in one year.
Market Cap
280.72B
Enterprise Value
n/a
Revenue
161.44B
Ranking
n/a
PE Ratio
15.13
Stock Price
19,080.00
Market Cap Chart
Since January 22, 2001, Korea United Pharm's market cap has increased from 34.22B to 280.72B, an increase of 720.41%. That is a compound annual growth rate of 8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 280.72B | 0.05% |
| Dec 30, 2025 | 280.57B | 4.73% |
| Dec 30, 2024 | 267.89B | -35.75% |
| Dec 28, 2023 | 416.97B | 18.68% |
| Dec 29, 2022 | 351.33B | -51.95% |
| Dec 30, 2021 | 731.24B | -28.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BNC Korea | 334.11B |
| Huons | 319.26B |
| Hyundai Pharmaceutical | 318.57B |
| CMG Pharmaceutical | 294.50B |
| HLB Pharmaceutical | 293.48B |
| Boditech Med | 279.91B |
| JW Holdings | 262.23B |
| AptaBio Therapeutics | 252.28B |